Trial Profile
Dose-ranging study for K-828 in the treatment of behavioral and psychological symptoms of dementia with Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Sodium valproate (Primary)
- Indications Dementia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kowa
- 25 May 2016 New trial record